Chen K W, Schröder R, Mueller T. "一种的合成方法" [P]. US Patent, US 10647841 B2, 2025-07-28.
Anderson J P, Klinger H, Thompson G K. "Method for the Synthesis of 2-{[4,6-bis({[(4-methylphenyl)carbamoyl]methyl}sulfanyl)-1,3,5-triazin-2-yl]sulfanyl}-N-(4-methylphenyl)acetamide" [P]. US Patent, US 10016185 B2, 2020-05-24.
发明人马晓峰,钱学锋,黄志刚. "A Process for Preparing High-Purity 2-{[4,6-bis({[(4-methylphenyl)carbamoyl]methyl}sulfanyl)-1,3,5-triazin-2-yl]sulfanyl}-N-(4-methylphenyl)acetamide" [P]. 中国发明专利, 专利号 CN 108480354 A, 授权公告日 2025-06-24.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2019, 1680, (3), 5674-5681.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2014, 1447, (10), 7069-7082.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-{[4,6-bis({[(4-methylphenyl)carbamoyl]methyl}sulfanyl)-1,3,5-triazin-2-yl]sulfanyl}-N-(4-methylphenyl)acetamide Using HRMS and NMR". J. Sep. Sci., 2010, 907, 3259-3264.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2018, 1366, (5), 6128-6156.